Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by juniper88on Dec 24, 2024 10:29am
32 Views
Post# 36376342

RE:RE:RE:RE:RE:RE:RE:HIV lipodystrophy causes morbidity and mortality

RE:RE:RE:RE:RE:RE:RE:HIV lipodystrophy causes morbidity and mortality I would add that they have to educate the doctors who greatly impact whether or not the customer buys and continues to buy the product.   Unless you see the doctor as the customer.   Either way these doctors should be able to understand all the scientific lingo.

Scarlett, thanks for digging up so much for all of us. Still it puzzles me that our brilliant CEO salesman isn't able to increase sales more with all this information. 

scarlet1967 wrote: "It's cash flow, debt, sales growth potential and the like."
How can they increase cash flow, reduce debt and improve sale growth potential?
Better revenues and cost control. In order to sell any product one has to convince and educate the customer about its benefits... enough said 




<< Previous
Bullboard Posts
Next >>